ATL1 and colorectal carcinoma: In particular, Zhang et al revealed that ATL‐II, another member of the ATL family with similar structural characteristics as ATL‐1, improved the chemotherapeutic efficacy against CRC by suppressing the viability and proliferation of CRC cells.